Annual report pursuant to Section 13 and 15(d)

Other current assets (Details)

v3.24.0.1
Other current assets (Details)
$ in Thousands, £ in Millions
Jan. 19, 2024
USD ($)
Jan. 19, 2024
GBP (£)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Other current assets        
Research and development credits receivable     $ 46,098 $ 30,162
Prepayments     9,954 9,472
Clinical materials     1,329 1,279
VAT receivable       490
Other current assets     2,412 1,927
Total     $ 59,793 $ 43,330
Amount of receivable from Research and Development credits $ 30,800 £ 24.2